Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years

Mount Sinai School of Medicine, Pediatrics, New York

State University of New York (SUNY), Syracuse

Center for Digestive Allergic and Immunologic Diseases, Williamsville

Children's Hospital of Philadelphia, Philadelphia

Thomas Jefferson University Medical College, Wilmington

Sinai Hospital of Baltimore, Baltimore

Virginia Commonwealth University, Richmond

Carilion Medical Center for Children, Roanoke

Pediatric Allergy and Immunology of Duke Medical Center, Durham

Greenville Health System, Greenville

Children's Center for Digestive Health Care, Atlanta

The Children's Hospital of Alabama, Birmingham

Nationwide Children's Hospital, Columbus

Cincinnati Children's, Cincinnati

Riley Hospital for Children, Indianapolis

Medical College of Wisconsin, Milwaukee

Minnesota Gastroenterology, Plymouth

University of Chicago, Chicago

Saint Louis University, St Louis

Children'S Memorial Hospital Division of Gastroenterology Hepatology & Nutrition, Chicago

Creighton University Medical Center, Omaha

Arkansas Children's Hospital/University of Arkansas for Medical Sciences, Little Rock

University of Texas Southwest Medical Center, Dallas

Denver Childrens At Aurora, Colorado, Aurora

1st Allergy and Clinical Research Center, Centennial

University of Utah School of Medicine, Salt Lake City

University of Arizona Dept. of Pediatrics, Tucson

Las Vegas Pediatric Gastroenterology Associates, Las Vegas

Children's Hospital of San Diego, San Diego

Children'S Hospital of Orange County Pediatric Subspecialty Faculty Division of Allergy and Asthma, Orange

Pediatric Allergy/Immunology, Palo Alto

Kaiser Permanente Hospital- Pediatric Gastroenterology, Hayward

Tuft's Floating Hospital, Boston

South Jersey Pediatric Gastroenterology, Mays Landing

Pediatric Allergy and Immunology, Edmonton

Pediatric Allergy & Immunology, Edmonton

University of Montreal, Montreal